A novel EGFR inhibitor suppresses survivin expression and tumor growth in human gefitinib-resistant EGFR-wild type and -T790M non-small cell lung cancer
Author:
Funder
Taiwan Ministry of Science and Technology
Ministry of Education of the People's Republic of China
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference51 articles.
1. Lung Cancer Statistics;Torre;Adv. Exp. Med. Biol.,2016
2. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020
3. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains;Ogiso;Cell,2002
4. EGF receptor trafficking: consequences for signaling and cancer;Tomas;Trends Cell Biol.,2014
5. N.L. Lill, N.I. Sever, Where EGF receptors transmit their signals, Sci Signal 5(243) (2012) pe41.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of YS-363 as a highly potent, selective, and orally efficacious EGFR inhibitor;Biomedicine & Pharmacotherapy;2023-11
2. Design and synthesis of gefitinib derivatives as potential drugs for cancer treatment: antiproliferative activity, molecular docking, and ADMET prediction;Letters in Drug Design & Discovery;2023-08-10
3. Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-07
4. Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer;Biochemical Pharmacology;2022-12
5. Design, synthesis, and antiproliferative evaluation of novel longifolene-derived tetraline pyrimidine derivatives with fluorescence properties;New Journal of Chemistry;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3